Meta Biomed Co., Ltd.

KOSDAQ:A059210 Stock Report

Market Cap: ₩93.5b

Meta Biomed Dividends and Buybacks

Dividend criteria checks 0/6

Meta Biomed is a dividend paying company with a current yield of 0.49%.

Key information

0.5%

Dividend yield

0%

Buyback Yield

Total Shareholder Yield0.5%
Future Dividend Yieldn/a
Dividend Growth0.3%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per share₩20.000
Payout ratio3%

Recent dividend and buyback updates

Recent updates

Meta Biomed (KOSDAQ:059210) Shareholders Will Want The ROCE Trajectory To Continue

Dec 17
Meta Biomed (KOSDAQ:059210) Shareholders Will Want The ROCE Trajectory To Continue

Earnings Tell The Story For Meta Biomed Co., Ltd. (KOSDAQ:059210) As Its Stock Soars 30%

Feb 26
Earnings Tell The Story For Meta Biomed Co., Ltd. (KOSDAQ:059210) As Its Stock Soars 30%

Here's How We Evaluate Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Dividend

Apr 11
Here's How We Evaluate Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Dividend

Meta Biomed's (KOSDAQ:059210) Stock Price Has Reduced 58% In The Past Five Years

Mar 14
Meta Biomed's (KOSDAQ:059210) Stock Price Has Reduced 58% In The Past Five Years

Are Meta Biomed's (KOSDAQ:059210) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 21
Are Meta Biomed's (KOSDAQ:059210) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Can Meta Biomed (KOSDAQ:059210) Continue To Grow Its Returns On Capital?

Feb 03
Can Meta Biomed (KOSDAQ:059210) Continue To Grow Its Returns On Capital?

Is Meta Biomed (KOSDAQ:059210) A Risky Investment?

Jan 13
Is Meta Biomed (KOSDAQ:059210) A Risky Investment?

Here's Why I Think Meta Biomed (KOSDAQ:059210) Is An Interesting Stock

Dec 26
Here's Why I Think Meta Biomed (KOSDAQ:059210) Is An Interesting Stock

Meta Biomed (KOSDAQ:059210) Share Prices Have Dropped 22% In The Last Five Years

Dec 08
Meta Biomed (KOSDAQ:059210) Share Prices Have Dropped 22% In The Last Five Years

Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Nov 20
Meta Biomed Co., Ltd.'s (KOSDAQ:059210) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: A059210 is not paying a notable dividend for the KR market, therefore no need to check if payments are stable.

Growing Dividend: A059210 is not paying a notable dividend for the KR market, therefore no need to check if payments are increasing.


Dividend Yield vs Market

Meta Biomed Dividend Yield vs Market
How does A059210 dividend yield compare to the market?
SegmentDividend Yield
Company (A059210)0.5%
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)4.0%
Industry Average (Medical Equipment)1.3%
Analyst forecast (A059210) (up to 3 years)n/a

Notable Dividend: A059210's dividend (0.49%) isn’t notable compared to the bottom 25% of dividend payers in the KR market (1.18%).

High Dividend: A059210's dividend (0.49%) is low compared to the top 25% of dividend payers in the KR market (3.96%).


Earnings Payout to Shareholders

Earnings Coverage: A059210 is not paying a notable dividend for the KR market.


Cash Payout to Shareholders

Cash Flow Coverage: A059210 is not paying a notable dividend for the KR market.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 18:57
End of Day Share Price 2025/01/31 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Meta Biomed Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution